Great work on Omicron, very reassuring- if you are boosted! Death rates are still too high for this to be as benign as the common cold and impact on children still unknown.
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma | NEJM nejm.org/doi/full/10.10… Kudos to Matt and the team, a significant step forward!!